JOANNE TOWERS: Open Payments
NPI 1932681376 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,543 in 205 payments from 21 companies in 2025. Trend: 2023 $4,311 · 2024 $5,264 · 2025 $7,543
Food & beverage: $6,381Consulting: $1,140Education: $19Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $1,442 |
| Galderma Laboratories, L.P. | 17 | $745 |
| ABBVIE INC. | 20 | $548 |
| Incyte Corporation | 16 | $534 |
| Lilly USA, LLC | 12 | $508 |
| Arcutis Biotherapeutics, Inc. | 6 | $479 |
| Regeneron Healthcare Solutions, Inc. | 14 | $457 |
| E.R. Squibb & Sons, L.L.C. | 16 | $391 |
| LEO Pharma Inc. | 17 | $334 |
| Novartis Pharmaceuticals Corporation | 14 | $334 |
Products named: Bimzelx, OPZELURA, NEMLUVIO, DUPIXENT, Zoryve, SKYRIZI, Sotyktu, TREMFYA.
Industry payments across VA — which companies pay providers there.
